LENZ Therapeutics, Inc. (LENZ)
NASDAQ
Closed
Oct 23, 2026
Day's Range
3.0652 wk Range
3.06Overview - LENZ - LENZ Therapeutics, Inc.
Key Statistics
Valuation
Enterprise Value
-120.14M
P/E (Trailing)
47.98
P/E (Forward)
-1.15
PEG Ratio
0.51
Price / Sales (TTM)
4.62
Price / Book
0.45
EV / EBITDA
0.88
Profitability
Gross Margin
94.89%
Profit Margin
97.81%
Operating Margin
-622.89%
Return on Assets
-37.35%
Return on Equity
-59.20%
Ownership
Shares Outstanding
31.41M
Float
18.39M
Short % of Shares Outstanding
55.29%
Held by Insiders
2.64%
Held by Institutions
110.11%
Price stats
Beta
1.73
50-Day Avg
4.23
200-Day Avg
8.34
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LENZ - LENZ Therapeutics, Inc.
Peers - LENZ - LENZ Therapeutics, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- LENZNASDAQLENZ Therapeutics, Inc.99.28MMarket Cap-890.19%52-week change47.98P/E (Trailing)97.81%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - LENZ - LENZ Therapeutics, Inc.
About
LENZ Therapeutics, Inc. is a pharmaceutical and biotechnology company focused on commercializing ophthalmic treatments that improve vision. Its primary product is VIZZ, an aceclidine-based eye drop approved for the treatment of presbyopia, the age-related loss of near vision. The company develops eye-care therapies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
